Quick Answer
AtriCure, Inc. reported Research And Development Expense of $99.21 million for the year ending 2025.
- AtriCure, Inc. showed an increase of +3.2% in Research And Development Expense from 2024 to 2025.
- This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $2.42 million | Q3 2010: $2.94 million | Q1 2011: $2.94 million | Q2 2011: $2.88 million | Q3 2011: $3.07 million | Q1 2012: $3.39 million | Q2 2012: $2.89 million | Q3 2012: $2.91 million | Q1 2013: $3.51 million | Q2 2013: $3.05 million | Q3 2013: $3.24 million | Q1 2014: $4.00 million | Q2 2014: $4.57 million | Q3 2014: $5.03 million | Q1 2015: $5.61 million | Q2 2015: $5.86 million | Q3 2015: $6.50 million | Q1 2016: $8.56 million | Q2 2016: $9.12 million | Q3 2016: $8.27 million | Q1 2017: $9.55 million | Q2 2017: $8.91 million | Q3 2017: $7.97 million | Q1 2018: $9.06 million | Q2 2018: $8.66 million | Q3 2018: $8.56 million | Q1 2019: $8.18 million | Q2 2019: $9.80 million | Q3 2019: $10.15 million | Q1 2020: $11.59 million | Q2 2020: $10.04 million | Q3 2020: $10.58 million | Q1 2021: $11.22 million | Q2 2021: $12.20 million | Q3 2021: $11.28 million | Q1 2022: $13.63 million | Q2 2022: $14.79 million | Q3 2022: $15.17 million | Q1 2023: $15.33 million | Q2 2023: $17.44 million | Q3 2023: $20.35 million | Q1 2024: $19.85 million | Q2 2024: $20.42 million | Q3 2024: $20.96 million | Q1 2025: $22.53 million | Q2 2025: $29.28 million | Q3 2025: $22.89 million.
- Over the full 17 years of available data (2009 to 2025), AtriCure, Inc.'s Research And Development Expense has grown by 769.1%.
- Historical annual values: Fiscal year 2025: $99.21 million | Fiscal year 2024: $96.18 million | Fiscal year 2023: $73.92 million | Fiscal year 2022: $57.34 million | Fiscal year 2021: $48.51 million | Fiscal year 2020: $43.07 million | Fiscal year 2019: $41.23 million | Fiscal year 2018: $34.72 million | Fiscal year 2017: $34.14 million | Fiscal year 2016: $35.82 million | Fiscal year 2015: $25.74 million | Fiscal year 2014: $18.60 million | Fiscal year 2013: $13.44 million | Fiscal year 2012: $12.15 million | Fiscal year 2011: $11.86 million | Fiscal year 2010: $11.53 million | Fiscal year 2009: $11.41 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: